Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.
- DOI
- 10.1002/acr2.90053
- Published
- 2026 May
- Container
- ACR open rheumatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/acr2.90053,
title = {Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.},
author = {Gossec L and Tillett W and Coates LC and Mease PJ and de Wit M and Gladman DD and Orbai AM and Proft F and Ink B and Bajracharya R and Lambert J and Healy P and Husni ME},
year = {2026},
journal = {ACR open rheumatology},
doi = {10.1002/acr2.90053},
url = {https://doi.org/10.1002/acr2.90053}
}RIS
TY - JOUR TI - Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies. AU - Gossec L AU - Tillett W AU - Coates LC AU - Mease PJ AU - de Wit M AU - Gladman DD AU - Orbai AM AU - Proft F AU - Ink B AU - Bajracharya R AU - Lambert J AU - Healy P AU - Husni ME PY - 2026 JO - ACR open rheumatology DO - 10.1002/acr2.90053 UR - https://doi.org/10.1002/acr2.90053 ER -
APA
L, G., W, T., LC, C., PJ, M., M, D. W., DD, G., AM, O., F, P., B, I., R, B., J, L., P, H., & ME, H. (2026). Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.. ACR open rheumatology. https://doi.org/10.1002/acr2.90053
Source records
- pubmed · retrieved 2026-09-26T07:35:26.367Z